Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Treatment for Schizophrenic Smokers

NCT00124683 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00124683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00124683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Treatment for Schizophrenic Smokers
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
May 31, 2007
Enrollment
59 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, tobacco use cessation, tobacco use disorder